Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMartínez Gómez, Xavier
dc.contributor.authorCurran Fàbregas, Adria
dc.contributor.authorCampins Martí, Magda
dc.contributor.authorAlemany Vilches, Laia
dc.contributor.authorRodrigo Pendás, Jose Angel
dc.contributor.authorBorruel Sainz, Natalia
dc.contributor.authorDíaz de Heredia Rubio, Maria Cristina
dc.contributor.authorMoraga Llop, Fernando
dc.date.accessioned2019-03-28T11:23:03Z
dc.date.available2019-03-28T11:23:03Z
dc.date.issued2019-02-14
dc.identifier.citationMartínez-Gómez X, Curran A, Campins M, Alemany L, Rodrigo-Pendás JÁ, Borruel N, et al. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016. Euro Surveill. 2019;24(7):1700857.
dc.identifier.issn1560-7917
dc.identifier.urihttp://hdl.handle.net/11351/3882
dc.descriptionHigh-risk populations; Human papillomavirus infection; Vaccines
dc.description.abstractINTRODUCTION: Although human papillomavirus (HPV) routine vaccination programmes have been implemented around the world and recommendations have been expanded to include other high-risk individuals, current recommendations often differ between countries in Europe, as well as worldwide. AIM: To find and summarise the best available evidence of HPV vaccination in high-risk patients aiding clinicians and public health workers in the day-to-day vaccine decisions relating to HPV in Spain. METHODS: We conducted a systematic review of the immunogenicity, safety and efficacy/effectiveness of HPV vaccination in high-risk populations between January 2006 and June 2016. HPV vaccination recommendations were established with levels of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. RESULTS: A strong recommendation about HPV vaccination was made in the following groups: HIV infected patients aged 9-26 years; men who have sex with men aged 9-26 years; women with precancerous cervical lesions; patients with congenital bone marrow failure syndrome; women who have received a solid organ transplant or hematopoietic stem cell transplantation aged 9-26 years; and patients diagnosed with recurrent respiratory papillomatosis. CONCLUSIONS: Data concerning non-routine HPV vaccination in populations with a high risk of HPV infection and associated lesions were scarce. We have developed a document to evaluate and establish evidence-based guidelines on HPV vaccination in high-risk populations in Spain, based on best available scientific evidence.
dc.language.isoeng
dc.publisherEuropean Centre for Disease Prevention and Control
dc.relation.ispartofseriesEurosurveillance;24(7)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectPapil·lomavirus - Vacunació - Espanya
dc.subject.meshPapillomavirus Infections
dc.subject.meshPapillomavirus Vaccines
dc.subject.meshSpain
dc.subject.mesh/epidemiology
dc.titleMultidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.2807/1560-7917.ES.2019.24.7.1700857
dc.subject.decsinfecciones por Papillomavirus
dc.subject.decsvacunas para papilomavirus
dc.subject.decsEspaña
dc.subject.decs/epidemiología
dc.relation.publishversionhttps://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.7.1700857
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Martínez-Gómez X] Servei de Medicina Preventiva i Epidemiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Curran A] Servei de Malalties Infeccioses, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Campins M] Servei de Medicina Preventiva i Epidemiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Alemany L] Programa de Recerca en Epidemiologia del Càncer, Institut Català d'Oncologia - IDIBELL CIBER Epidemiología y Salud Pública, Barcelona, Spain. [Rodrigo-Pendás JÁ] Servei de Medicina Preventiva i Epidemiologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Borruel N] Unitat d'Atenció Crohn-Colitis, Servei d'Aparell Digestiu, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Díaz-de-Heredia C] Servei d'Oncologia i Hematologia Pediàtrica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Moraga-Llop FA] Asociación Española de Vacunología, Barcelona, Spain.
dc.identifier.pmid30782268
dc.identifier.wosWOS:000458642200002
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record